Skip to content

Clorox, Chevron, and Bristol Myers Squibb shine as top dividend stocks despite market hurdles

From consumer staples to pharma, these three giants offer steady payouts—but can they overcome rising costs and patent risks? Investors weigh the rewards.

This image is clicked in a room, where it looks like Store. There are so many bottles in this image...
This image is clicked in a room, where it looks like Store. There are so many bottles in this image and cans. There is a Banner in the middle which is indicating Supra brand. Bottom right corner there is a logo LM.

Clorox, Chevron, and Bristol Myers Squibb shine as top dividend stocks despite market hurdles

Three major companies—Clorox, Chevron, and Bristol Myers Squibb—are drawing investor attention for their strong dividend yields and steady performance. Each offers different opportunities, from consumer goods to energy and pharmaceuticals, despite facing their own market challenges.

Clorox, led by CEO Linda Rendle, maintains a 4.9% dividend yield and is on track to become a Dividend King within a few years. The company manages a diverse portfolio of well-known brands but currently deals with rising costs, the aftermath of a data breach, and risks tied to a new computer system. A $1,000 investment in Clorox would buy around nine shares.

These three companies provide reliable dividend options, though each faces distinct operational challenges. Clorox aims for Dividend King status, Chevron maintains a long streak of dividend growth, and Bristol Myers Squibb continues to navigate patent management successfully. Their share accessibility and yield rates make them notable choices for income investors.

Read also:

Latest